首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Systemic lupus erythematosus sera antilymphocyte reactivity: detection of antibodies to Tac-antigen positive T cell lines.
【2h】

Systemic lupus erythematosus sera antilymphocyte reactivity: detection of antibodies to Tac-antigen positive T cell lines.

机译:系统性红斑狼疮血清抗淋巴细胞反应性:检测针对Tac抗原阳性T细胞系的抗体。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sera obtained from patients with systemic lupus erythematosus (SLE) were tested for their reactivity to cell lines derived from cutaneous T-cell lymphoma (CTCL), or adult T cell leukaemia (ATL), and with other cell lines, by indirect immunofluorescence method. Approximately one half of SLE sera reacted with the surface antigens of HUT-102 cells, a cell line from CTCL, which constitutively expresses Tac antigen. The titre tended to be higher in the active than in the inactive stage. These positive sera also reacted with other neoplastic or normal T cell lines having Tac antigen. SLE sera reacting with HUT-102 surface antigens were further examined for their reactivities to Tac antigen, the putative IL-2 receptor, using HUT-102 or ATL-2. Pretreatment with anti-Tac monoclonal antibody partially blocked the reactivities to HUT-102 surface antigens in nine of 15 SLE sera tested. The binding of 125I-labelled anti-Tac monoclonal antibody was displaced by the addition of sera from six of 15 SLE patients. In addition, nine of the 15 SLE sera could inhibit the binding of 125I-labelled IL-2 to ATL-2 cells. These results suggested that some of SLE sera contained antibodies against the IL-2 receptor.
机译:通过间接免疫荧光法测试从系统性红斑狼疮(SLE)患者获得的血清对源自皮肤T细胞淋巴瘤(CTCL)或成人T细胞白血病(ATL)的细胞系以及其他细胞系的反应性。大约一半的SLE血清与HUT-102细胞的表面抗原反应,这是一种来自CTCL的细胞系,可组成性表达Tac抗原。活性阶段的效价往往高于非活性阶段的效价。这些阳性血清还与其他具有Tac抗原的赘生性或正常T细胞系反应。使用HUT-102或ATL-2,进一步检查了与HUT-102表面抗原反应的SLE血清与Tac抗原(假定的IL-2受体)的反应性。用抗Tac单克隆抗体进行的预处理在15种SLE血清中的9种中部分阻断了对HUT-102表面抗原的反应性。通过从15位SLE患者中的6位血清中添加血清,取代了125I标记的抗Tac单克隆抗体的结合。另外,在15个SLE血清中,有9个可以抑制125I标记的IL-2与ATL-2细胞的结合。这些结果表明一些SLE血清含有针对IL-2受体的抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号